46 related articles for article (PubMed ID: 22584412)
1. Effects of anidulafungin and voriconazole, singly and in combination, on cytokine/chemokine production by human monocyte-derived macrophages infected with Candida glabrata or activated by lipopolysaccharide.
Baltch AL; Lawrence D; Ritz WJ; Andersen N; Bopp LH; Michelsen PB; Carlyn CJ; Smith RP
Chemotherapy; 2012; 58(2):146-51. PubMed ID: 22584412
[TBL] [Abstract][Full Text] [Related]
2. Effects of echinocandins on cytokine/chemokine production by human monocytes activated by infection with Candida glabrata or by lipopolysaccharide.
Baltch AL; Lawrence DA; Ritz WJ; Andersen NJ; Bopp LH; Michelsen PB; Carlyn CJ; Smith RP
Diagn Microbiol Infect Dis; 2012 Mar; 72(3):226-33. PubMed ID: 22209510
[TBL] [Abstract][Full Text] [Related]
3. Effects of voriconazole, granulocyte-macrophage colony-stimulating factor, and interferon gamma on intracellular fluconazole-resistant Candida glabrata and Candida krusei in human monocyte-derived macrophages.
Baltch AL; Bopp LH; Smith RP; Ritz WJ; Carlyn CJ; Michelsen PB
Diagn Microbiol Infect Dis; 2005 Aug; 52(4):299-304. PubMed ID: 15893901
[TBL] [Abstract][Full Text] [Related]
4. Anticandidal effects of voriconazole and caspofungin, singly and in combination, against Candida glabrata, extracellularly and intracellularly in granulocyte-macrophage colony stimulating factor (GM-CSF)-activated human monocytes.
Baltch AL; Bopp LH; Smith RP; Ritz WJ; Michelsen PB
J Antimicrob Chemother; 2008 Dec; 62(6):1285-90. PubMed ID: 18772160
[TBL] [Abstract][Full Text] [Related]
5. Time-kill studies with micafungin and voriconazole against Candida glabrata intracellularly in human monocyte-derived macrophages and extracellularly in broth.
Baltch AL; Ritz W; Bopp LH; Michelsen PB; Smith RP
Diagn Microbiol Infect Dis; 2011 Aug; 70(4):468-74. PubMed ID: 21767703
[TBL] [Abstract][Full Text] [Related]
6. Comparison of antifungal susceptibilities to fluconazole and voriconazole of oral Candida glabrata isolates from head and neck radiation patients.
Burn AK; Fothergill AW; Kirkpatrick WR; Coco BJ; Patterson TF; McCarthy DI; Rinaldi MG; Redding SW
J Clin Microbiol; 2004 Dec; 42(12):5846-8. PubMed ID: 15583322
[TBL] [Abstract][Full Text] [Related]
7. Effect of protein binding on the activity of voriconazole alone or combined with anidulafungin against Aspergillus spp. using a time-kill methodology.
Cafini F; Sevillano D; Alou L; Gómez-Aguado F; Corcuera MT; González N; Guinea J; Prieto J
Rev Esp Quimioter; 2012 Mar; 25(1):47-55. PubMed ID: 22488542
[TBL] [Abstract][Full Text] [Related]
8. Post-antifungal effects and time-kill studies of anidulafungin, caspofungin, and micafungin against Candida glabrata and Candida parapsilosis.
Smith RP; Baltch A; Bopp LH; Ritz WJ; Michelsen PP
Diagn Microbiol Infect Dis; 2011 Oct; 71(2):131-8. PubMed ID: 21865002
[TBL] [Abstract][Full Text] [Related]
9. Is decreased HIV-1 infectivity of placental macrophages caused by high levels of beta-chemokines?
Meléndez J; García V; Sánchez E; Delgado R; Torres G; Meléndez-Guerrero LM
Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL51-9. PubMed ID: 11936874
[TBL] [Abstract][Full Text] [Related]
10. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
Takakura S; Fujihara N; Saito T; Kudo T; Iinuma Y; Ichiyama S
J Antimicrob Chemother; 2004 Feb; 53(2):283-9. PubMed ID: 14688039
[TBL] [Abstract][Full Text] [Related]
11. Extracellular high mobility group box-1 inhibits R5 and X4 HIV-1 strains replication in mononuclear phagocytes without induction of chemokines and cytokines.
Cassetta L; Fortunato O; Adduce L; Rizzi C; Hering J; Rovere-Querini P; Bianchi ME; Alfano M; Poli G
AIDS; 2009 Mar; 23(5):567-77. PubMed ID: 19194273
[TBL] [Abstract][Full Text] [Related]
12. Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program.
Pfaller MA; Diekema DJ; Gibbs DL; Newell VA; Barton R; Bijie H; Bille J; Chang SC; da Luz Martins M; Duse A; Dzierzanowska D; Ellis D; Finquelievich J; Gould I; Gur D; Hoosen A; Lee K; Mallatova N; Mallie M; Peng NG; Petrikos G; Santiago A; Trupl J; VanDen Abeele AM; Wadula J; Zaidi M;
Diagn Microbiol Infect Dis; 2010 Jun; 67(2):162-71. PubMed ID: 20338711
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of nitric oxide by Neisseria meningitidis modifies release of NO-regulated cytokines and chemokines by human macrophages.
Stevanin TM; Laver JR; Poole RK; Moir JW; Read RC
Microbes Infect; 2007 Jul; 9(8):981-7. PubMed ID: 17544805
[TBL] [Abstract][Full Text] [Related]
14. In vitro activities of voriconazole in combination with three other antifungal agents against Candida glabrata.
Barchiesi F; Spreghini E; Maracci M; Fothergill AW; Baldassarri I; Rinaldi MG; Scalise G
Antimicrob Agents Chemother; 2004 Sep; 48(9):3317-22. PubMed ID: 15328091
[TBL] [Abstract][Full Text] [Related]
15. Activities of fluconazole and voriconazole against bloodstream isolates of Candida glabrata and Candida krusei: a 14-year study in a Spanish tertiary medical centre.
Quindós G; Sánchez-Vargas LO; Villar-Vidal M; Eraso E; Alkorta M; Hernández-Almaraz JL
Int J Antimicrob Agents; 2008 Mar; 31(3):266-71. PubMed ID: 18054468
[TBL] [Abstract][Full Text] [Related]
16. Effect of titanium surface topography on macrophage activation and secretion of proinflammatory cytokines and chemokines.
Refai AK; Textor M; Brunette DM; Waterfield JD
J Biomed Mater Res A; 2004 Aug; 70(2):194-205. PubMed ID: 15227664
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of anidulafungin against biofilms of different Candida species in long-term trials of continuous flow cultivation.
Bernhardt H; Knoke M; Bernhardt J
Mycoses; 2011 Nov; 54(6):e821-7. PubMed ID: 21672048
[TBL] [Abstract][Full Text] [Related]
18. Synergism of voriconazole and terbinafine against Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
Weig M; Müller FM
Antimicrob Agents Chemother; 2001 Mar; 45(3):966-8. PubMed ID: 11181393
[TBL] [Abstract][Full Text] [Related]
19. Voriconazole inhibits biofilm formation in different species of the genus Candida.
Valentín A; Cantón E; Pemán J; Martínez JP
J Antimicrob Chemother; 2012 Oct; 67(10):2418-23. PubMed ID: 22733651
[TBL] [Abstract][Full Text] [Related]
20. Additive antifungal activity of anidulafungin and human neutrophils against Candida parapsilosis biofilms.
Katragkou A; Chatzimoschou A; Simitsopoulou M; Georgiadou E; Roilides E
J Antimicrob Chemother; 2011 Mar; 66(3):588-91. PubMed ID: 21138910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
